Barclays PLC Glaukos Corp Put Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $24.7 Million - $34.9 Million	612,600 Added 1392.27%	656,600 $29.2 Million
Q3 2021 Nov 09, 2021	SELL	$47.43 - $84.23 $545,445 - $968,645	-11,500 Reduced 20.72%	44,000 $2.12 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $2.73 Million - $3.38 Million	43,000 Added 344.0%	55,500 $4.19 Million
Q1 2019 May 15, 2019	SELL	$50.75 - $80.54 $2.66 Million - $4.23 Million	-52,500 Reduced 80.77%	12,500 $980,000
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $1.48 Million - $2.65 Million	38,800 Added 148.09%	65,000 $4.22 Million
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $723,644 - $1.17 Million	26,200 New	26,200 $1.07 Million

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.